Building infrastructure for digital health using Open innovation 2.0 in
                        co design of a meta data registry framework to support integrated
                        care

Hussey, Pamela; Tully, Martin; Farrell, Sharon; Coyne, Eamon; Connolly, Peter; Glynn, Carole; Qurashi, Muhammad Zubair; Staines, Anthony; McGlinn, Kris

doi:10.5334/ijic.s3018

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Electronic health records could also be optimized by open innovation in a bottom-up approach, by gathering the feedback of participants attending a workshop who worked together to identify shortcomings and propose solutions to streamline the steps in the workflow ( Murphy et al, 2020 ). To promote the building of infrastructure for digital health, some open-source meta-data registry framework and core catalogs could be shared with the community to encourage collaborations and cross-disciplinary deployment ( Hussey et al, 2019 ). Taking into consideration that information technologies were historically one of the pioneer areas adopting open innovation, as well as the recent development boost in sectors such as telehealth, artificial intelligence, virtual reality, and wearable technologies, it is very likely that in the future, there will be an increasing application of open innovation strategies in areas such as digital therapeutics and digital health technologies.…”

Section: Discussionmentioning

confidence: 99%

Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis

et al. 2021

View full text Add to dashboard Cite

Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining social media attention remains largely unexplored. The scientific literature of open innovation was examined by means of bibliometric analyses to identify the most prolific authors, organizations, countries, journals, research areas, and recurring terms. By accessing the Web of Science Core Collection and Altmetric electronic databases, citation-related and Altmetric data were evaluated. Public-private partnerships and a selection of newly introduced potential novel drugs in the analyzed publications were identified. North America and Europe were the major literature contributors. Research outputs were mainly published in journals focused on business and economics, pharmacology and pharmacy, and engineering. Many pharmaceutical and biotechnological companies contributed to the analyzed publications, with higher mean citation counts and social media attention (Altmetric score) than nonindustry articles. Public-private partnerships fostered financial support, sharing of expertise and intellectual property, and research collaborations. In summary, open innovation might serve as a powerful strategy to both benefit the involved industry entities and accelerate the development of solutions and products for the betterment of human health.

show abstract

Section: Discussionmentioning

confidence: 99%

Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis

et al. 2021

View full text Add to dashboard Cite

show abstract

Open Innovation in Healthcare Ecosystem – a systematic review

Torab-Miandoab

Samad‐Soltani

Rezaei‐Hachesu

2021

Preprint

View full text Add to dashboard Cite

Background: Several countries are facing significant troubles of health services, particularly rising prices. Innovative technologies and services are expected to help boost medical quality and cut costs. In this sense, there is a lack of innovative work in spite of a growing interest in open innovation and approaches that advocate for expanded cooperation among various actors in healthcare. Objective: This paper describes the findings of a study concerning the commitment of the healthcare sector to open innovation. Materials and methods: The search for literature focused on English-language papers to 12 January 2020. Based on the indicated criteria for inclusion, 29 articles were included. Results: Results show that most experiments concentrate on the areas of pharmaceutical research (drug discovery) and health informatics (health information systems and infrastructures) that were brought out as concepts or applied as pilot and prototype. Conclusions: The participation of the healthcare sector limited in open innovation, and more work is required with an emphasis how to get open innovation.

show abstract

Building infrastructure for digital health using Open innovation 2.0 in co design of a meta data registry framework to support integrated care

Abstract: Open innovation 2.0 in co design of a meta data registry framework to support integrated care..

Cited by 2 publications

References 0 publications

Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis

Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis

Open Innovation in Healthcare Ecosystem – a systematic review

Contact Info

Product

Resources

About